It was reported that inhibition of PPT1 with specific PPT1 inhibitors hydroxychloroquine (HCQ) or dimeric CQ DC661 induced interferon‐β secretion in macrophages and enhanced the antitumor efficacy of the anti‐PD‐1 antibody in melanoma [133]. This evidence concerns the gene PPT1 and melanoma.